Country for PR: China
Contributor: PR Newswire Asia (China)
Tuesday, April 26 2022 - 19:56
AsiaNet
SonoScape S-Fetus 4.0 Release to Simplify Sonography Process
SHENZHEN, China, April 26, 2022 /PRNewswire-AsiaNet/ --

SonoScape Medical Corp. today announced the release of S-Fetus 4.0, the latest 
software upgrade of the company's flagship ultrasound product offering. This 
technical breakthrough marks S-Fetus 4.0 as the globally first smart obstetric 
screening technology based on deep learning.

Leveraging the deep learning techniques, the S-Fetus 4.0 Obstetric Screening 
Assistant allows doctors to automatically acquire standard planes and measure 
fetal biometry with fast performance and accuracy. Without the need for 
manually repetitive operation of the device, the system was designed with 
one-click simple touch to streamline the sonogram pocess and improve scanning 
efficiency. "Our obstetric screening assistant has achieved breakthroughs in 
terms of performance and scalability and now it can offer more efficient means 
of smart obstetric diagnosis that assist doctors in precise work to ensure 
better patient outcomes", said Zhou Guoyi, Head of SonoScape Medical Innovation 
Research Center.

To improve service capability, SonoScape applied this newly upgrade to a 
variety of high-end ultrasound equipment. The S-Fetus 4.0 is going to run on 
SonoScape S60, P60, P60 Exp, S50 Elite, P50 Elite and P40 Elite, both in the 
North America and ROW Region. "With our commitment to the independent R&D and 
innovation of medical equipment, our cutting edge technology has been able to 
realize its potential to serve medical institutions around the world", 
commented Naizhang Feng, Vice President of SonoScape Ultrasound Division.

The S-Fetus 4.0 Obstetric Screening Assistant is powered by Intel® oneAPI 
Toolkits, for more information please check 
https://www.intel.com/content/www/us/en/healthcare-it/resources/sonoscape-oneapi-brief.html


About SonoScape

Founded in 2002 in Shenzhen China, SonoScape has committed itself to "Caring 
for Life through Innovation" by providing ultrasound and endoscopy solutions. 
With seamless support, SonoScape provides worldwide sales and service in more 
than 130 countries, benefiting local hospitals and doctors with comprehensive 
imaging diagnostic evidence and technical support. Investing 20% of total 
revenue into R&D annually, SonoScape establishes seven R&D centers in Shenzhen, 
Shanghai, Harbin, Wuhan, Tokyo, Seattle, and Silicon Valley, with more advanced 
products to be introduced into the pipeline.

For more information, please visit us at https://sonoscape.com/.

SOURCE  SonoScape Medical Corporation

Image Attachments Links:

   Link: https://iop.asianetnews.net/view-attachment?attach-id=419948

   Caption: SonoScape S-Fetus 4.0 Obstetric Screening Assistant

Attachments
image1.jpg
Translations

Japanese